HEMOGENYX PHARMACEUTICALS PLC
Develops novel therapies for life-threatening blood disorders, cancers, and autoimmune diseases.
HEMO | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYX3WZ24
- LEI:
- 2138008L93GYU5GN6179
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, 60 GRACECHURCH STREET, EC3V 0HR LONDON
- Website:
- https://hemogenyx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Hemogenyx Pharmaceuticals PLC is a clinical-stage biotechnology company engaged in the discovery, development, and commercialization of novel therapies. The company focuses on creating breakthrough treatments for life-threatening conditions, primarily targeting blood disorders, such as cancers, autoimmune diseases, and viral infections. Its product pipeline is designed to address significant unmet medical needs and improve patient outcomes in areas related to bone marrow transplantation and cell therapies.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HEMOGENYX PHARMACEUTICALS PLC and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-17 08:00 |
Legal Proceedings Report
Third Patient Safety
|
English | 16.5 KB | |
| 2025-09-11 08:00 |
Regulatory News Service
Invitation to Participate at DCNY Summit
|
English | 11.6 KB | |
| 2025-09-08 08:00 |
Regulatory News Service
Manufacturing Partnership with Made Scientific
|
English | 13.2 KB | |
| 2025-09-03 14:57 |
Share Issue/Capital Change
Exercise of Warrants and Issue of Equity
|
English | 11.8 KB | |
| 2025-08-15 08:00 |
Regulatory News Service
Third Patient Treated with HG-CT-1 CAR-T Therapy
|
English | 12.2 KB | |
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 10.1 KB | |
| 2025-07-29 09:00 |
Share Issue/Capital Change
Placing to Raise £250,000 and Director’s Dealing
|
English | 26.5 KB | |
| 2025-07-16 08:00 |
Regulatory News Service
Hemogenyx Awarded Grant
|
English | 14.6 KB | |
| 2025-06-30 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 9.6 KB | |
| 2025-06-03 15:02 |
Director's Dealing
Placing to Raise £451,250 and Director’s Dealing
|
English | 26.1 KB | |
| 2025-06-03 08:00 |
Legal Proceedings Report
Second Patient Passes Initial Safety Tests
|
English | 14.9 KB | |
| 2025-05-31 12:30 |
Post-Annual General Meeting Information
Resolutions passed at Annual General Meeting of Hemogenyx Pharmaceuticals plc o…
|
English | 33.9 KB | |
| 2025-05-29 15:06 |
Post-Annual General Meeting Information
Result of AGM
|
English | 27.1 KB | |
| 2025-05-20 21:50 |
Annual Report (ESEF)
Annual Report & Financial Statements for the Year Ended 31 December 2024
|
English | 673.1 KB | |
| 2025-05-20 21:50 |
Annual Report
Annual Report & Financial Statements for the Year Ended 31 December 2024
|
English | 2.4 MB |
Automate Your Workflow. Get a real-time feed of all HEMOGENYX PHARMACEUTICALS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for HEMOGENYX PHARMACEUTICALS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
